Breast Cancer
Studies conducted at University Hospital on breast cancer recently published
Published in Drug Week, May 1st, 2009
According to recent research published in the journal Anticancer Research, "Optimal chemotherapy (CT) for advanced breast treatment should be effective, well tolerated and convenient. In this study the efficacy and safety of the fully oral combination of oral vinorelbine (Navelbine Oral) plus capecitabine (Xeloda) in metastatic breast cancer (MBC) patients pretreated with anthracycline, was evaluated."
"In this phase II multicenter study, this combination CT was given as a first- or second-line therapy for MBC. The treatment schedule was: oral vinorelbine 60 mg/m(2) day I and day, 8 plus capecitabine 1,000 mg/m(2) twice daily from day I to day 14, ever-v 21 days....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2009-05-01)
More Articles from Drug Week
- American Academy of Sleep Medicine
Melatonin is an effective treatment for sleep problems in children with autism - American Academy of Sleep Medicine
Treating sleep disorders in people with traumatic brain injury may not eliminate symptoms - American Cancer Society
Racial disparities persist in the treatment of lung cancer - American College of Cardiology
Depression after heart disease ups risk of heart failure - American Society for Nutrition
Low glycemic breakfast may increase benefits of working out - Biotechnology and Biological Sciences Research Council
Biological FM signal maintains inflammation in cancer, asthma and other diseases - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
